Leukoencephalopathy

Results: 60



#Item
51Microsoft Word - NOMU0855_NDA[removed]Myfortic - PML  DHCP letter 13May08_clean_V2.doc

Microsoft Word - NOMU0855_NDA[removed]Myfortic - PML DHCP letter 13May08_clean_V2.doc

Add to Reading List

Source URL: www.fda.gov

Language: English
52Guidance for Industry and FDA Staff - Class II Special Controls Guidance Document:  In Vitro diagnostic devices for JCV antibody detection

Guidance for Industry and FDA Staff - Class II Special Controls Guidance Document: In Vitro diagnostic devices for JCV antibody detection

Add to Reading List

Source URL: www.fda.gov

Language: English
53[removed]ULF Fall Newsletter_cover

[removed]ULF Fall Newsletter_cover

Add to Reading List

Source URL: ulf.org

Language: English - Date: 2013-11-18 10:01:53
54510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY A. 510(k) Number: K112394 B. Purpose for Submission:

510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY A. 510(k) Number: K112394 B. Purpose for Submission:

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2012-01-27 15:10:15
55Latest advice for medicines users The monthly newsletter from the Medicines and Healthcare products Regulatory Agency and its independent advisor the Commission on Human Medicines Volume 4, Issue 8, March[removed]Contents

Latest advice for medicines users The monthly newsletter from the Medicines and Healthcare products Regulatory Agency and its independent advisor the Commission on Human Medicines Volume 4, Issue 8, March[removed]Contents

Add to Reading List

Source URL: www.mhra.gov.uk

Language: English - Date: 2011-12-12 06:50:27
56Microsoft Word - Master USPI_Rituxan.doc

Microsoft Word - Master USPI_Rituxan.doc

Add to Reading List

Source URL: www.gene.com

Language: English - Date: 2014-03-31 07:24:10
57October 2009 IMPORTANT DRUG WARNING Regarding RITUXAN® (Rituximab) Dear Healthcare Professional: Genentech, Inc. and Biogen Idec, Inc. would like to inform you of important new safety information regarding Rituxan (ritu

October 2009 IMPORTANT DRUG WARNING Regarding RITUXAN® (Rituximab) Dear Healthcare Professional: Genentech, Inc. and Biogen Idec, Inc. would like to inform you of important new safety information regarding Rituxan (ritu

Add to Reading List

Source URL: www.gene.com

Language: English - Date: 2014-03-31 07:24:11
58MEDICATION GUIDE TYSABRI® (tie-SA-bree) (natalizumab) injection, for intravenous use Read this Medication Guide before you start receiving TYSABRI and before you receive each dose. There may be new information. This Med

MEDICATION GUIDE TYSABRI® (tie-SA-bree) (natalizumab) injection, for intravenous use Read this Medication Guide before you start receiving TYSABRI and before you receive each dose. There may be new information. This Med

Add to Reading List

Source URL: www.tysabri.com

Language: English - Date: 2013-12-17 18:23:06
59Clinical significance of serological biomarkers and neuropsychological performances in patients with temporal lobe epilepsy

Clinical significance of serological biomarkers and neuropsychological performances in patients with temporal lobe epilepsy

Add to Reading List

Source URL: www.ncbi.nlm.nih.gov

Language: English
60The pattern and predictors of mortality of HIV/AIDS patients with neurologic manifestation in Ethiopia: a retrospective study

The pattern and predictors of mortality of HIV/AIDS patients with neurologic manifestation in Ethiopia: a retrospective study

Add to Reading List

Source URL: www.ncbi.nlm.nih.gov

Language: English